Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
Cover
Document and Entity Information
Financial Statements
Consolidated Statements of Financial Position
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Changes in Equity
Consolidated Statements of Changes in Equity (Parenthetical)
Consolidated Statements of Cash Flows
Consolidated Statements of Cash Flows (Parenthetical)
Notes to Financial Statements
General
Significant Accounting Policies
Significant Accounting Judgments, Estimates and Assupmtions Used in the Preparation of the Financial Statements
Disclusure of New IFRS in the Period
Accounts Receivable and Prepaid Expenses
Long-Term Investment
Property, Plant and Equipment, Net
Other Accounts Payable
Financial Instruments
Contingent Liabilities and Commitments
Equity
Share-Based Payment Transactions
Research and Development Expenses
General and Administrative Expenses
Finance (Income)
Loss Per Share
Taxes on Income
Transactions with Related Parties
Subsequent Events
Accounting Policies
Significant Accounting Policies (Policies)
Notes Tables
Significant Accounting Policies (Tables)
Accounts Receivable and Prepaid Expenses (Tables)
Property, Plant and Equipment, Net (Tables)
Other Accounts Payable (Tables)
Financial Instruments (Tables)
Contingent Liabilities and Commitments (Tables)
Equity (Tables)
Share-Based Payment Transactions (Tables)
Research and Development Expenses (Tables)
General and Administrative Expenses (Tables)
Finance (Income) (Tables)
Loss Per Share (Tables)
Transactions with Related Parties (Tables)
Notes Details
General (Details)
Significant Accounting Policies (Details)
Significant Accounting Policies (Details Textual)
Disclusure of New Ifrs in the Period (Details)
Accounts Receivable and Prepaid Expenses (Details)
Long-Term Investment (Details)
Property, Plant and Equipment, Net (Details)
Other Accounts Payable (Details)
Financial Instruments (Details)
Financial Instruments (Details 1)
Financial Instruments (Details 2)
Financial Instruments (Details 3)
Financial Instruments (Details 4)
Financial Instruments (Details Textual)
Contingent Liabilities and Commitments (Details)
Contingent Liabilities and Commitments (Details Textual)
Equity (Details)
Equity (Details 1)
Equity (Details Textual)
Share-Based Payment Transactions (Details)
Share-Based Payment Transactions (Details 1)
Share-Based Payment Transactions (Details 2)
Share-Based Payment Transactions (Details Textual)
Research and Development Expenses (Details)
General and Administrative Expenses (Details)
Finance (Income) (Details)
Loss Per Share (Details)
Loss Per Share (Details Textual)
Taxes on Income (Details)
Transactions with Related Parties (Details)
Subsequent Events (Details)
Other Accounts Payable
v3.8.0.1
Other Accounts Payable
12 Months Ended
Dec. 31, 2017
Other Accounts Payable
OTHER ACCOUNTS PAYABLE
NOTE 8:-
OTHER ACCOUNTS PAYABLE
December 31,
2017
2016
NIS in thousands
Employees and payroll accruals
780
401
Accrued expenses
2,689
3,187
3,469
3,588
X
- Definition
The disclosure of other accounts payable.
+ References
No definition available.
+ Details
Name:
CANF_DisclosureOfOtherAccountsPayableExplanatoryTextBlock
Namespace Prefix:
CANF_
Data Type:
nonnum:textBlockItemType
Balance Type:
na
Period Type:
duration
X
- References
No definition available.
+ Details
Name:
CANF_OtherAccountsPayableAbstract
Namespace Prefix:
CANF_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration